Transcription of Annual Report 2018 - GSK
{{id}} {{{paragraph}}}
Annual Report 2018. GSK Annual Report 2018. Contents Strategic Report Corporate Governance Financial statements GSK at a glance 01 Chairman's Governance statement 66 Directors' statement of Chairman's statement 02 Our Board 68 responsibilities 126. CEO's statement 03 Our Corporate Executive Team 71 Independent Auditor's Report 128. Financial performance 04 Leadership and effectiveness 72 Financial statements 140. Our long-term priorities 07 Nominations Committee Report 77 Notes to the financial statements 144. Key performance indicators 08 Accountability 79 Financial statements of Industry trends 09 Audit & Risk Committee Report 79 GlaxoSmithKline plc prepared Stakeholder engagement 11 Relations with stakeholders 89 under UK GAAP 219. Our business model 12 Science Committee Report 91. Pharmaceuticals 13 Corporate Responsibility Investor information Vaccines 18 Committee Report 92 Quarterly trend 224. Consumer Healthcare 21 Five-year record 229.
Succession. In 2018, we announced that Simon Dingemans would step down as Chief Financial Officer at this coming AGM after more than eight years with GSK. I would like to thank him for his service to GSK. Succeeding Simon, is Iain Mackay, formerly Group Finance Director for HSBC, who we welcomed to the Board in January 2019.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}